Synopsis
Synopsis
0
VMF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Apo Pravastatin
2. Apo-pravastatin
3. Bristacol
4. Cs 514
5. Cs-514
6. Cs514
7. Elisor
8. Eptastatin
9. Lin Pravastatin
10. Lin-pravastatin
11. Lipemol
12. Liplat
13. Lipostat
14. Mevalotin
15. Nu Pravastatin
16. Nu-pravastatin
17. Prareduct
18. Pravachol
19. Pravacol
20. Pravasin
21. Pravastatin
22. Pravastatin Monosodium Salt, (6 Beta)-isomer
23. Pravastatin Sodium Salt
24. Pravastatin Tert Octylamine Salt
25. Pravastatin Tert-octylamine Salt
26. Pravastatin, (6 Beta)-isomer
27. Rms 431
28. Rms-431
29. Rms431
30. Selektine
31. Sodium Salt, Pravastatin
32. Sq 31,000
33. Sq 31000
34. Sq-31,000
35. Sq-31000
36. Sq31,000
37. Sq31000
38. Vasten
1. 81131-70-6
2. Pravachol
3. Mevalotin
4. Selektine
5. Elisor
6. Pravaselect
7. Lipostat
8. Eptastatin Sodium
9. Cs-514
10. Pravastatin Sodium Salt
11. Pravastatin (sodium)
12. Dehypotin Protect
13. Sq-31000
14. Sq-31,000
15. Chebi:8361
16. Bristacol
17. Lipemol
18. Prareduct
19. Pravacol
20. Pravasin
21. 3m8608uq61
22. Nsc-759253
23. Sodium;(3r,5r)-7-[(1s,2s,6s,8s,8ar)-6-hydroxy-2-methyl-8-[(2s)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate
24. Aplactin
25. Lipidal
26. Liprevil
27. Pralidon
28. Pravasine
29. Sanaprav
30. Selipran
31. Vasen
32. Epastatin Sodium
33. Dsstox_cid_27525
34. Dsstox_rid_82395
35. Dsstox_gsid_47525
36. Liplat
37. Vasten
38. Pravastatin, Sodium Salt
39. (3r,5r)-3,5-dihydroxy-7-((1s,2s,6s,8s,8ar)-6-hydroxy-2-methyl-8-(((s)-2-methylbutanoyl)oxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoic Acid, Sodium Salt
40. Cas-81131-70-6
41. Pravastatin Natrium Mayrho Fer
42. Sq 31000
43. 3-beta-hydroxycompactin Sodium Salt
44. Drg-0319
45. Chembl690
46. Unii-3m8608uq61
47. Cres Pravastatin
48. Pravachol (tn)
49. Ncgc00095183-01
50. Pravastatin Sodium [usan:usp:jan]
51. Mfcd00887601
52. Pravastatinsodium,(s)
53. Cs-514 Sodium
54. Pravastatin Sodium- Bio-x
55. Schembl3013
56. Sodium (+)-(betar,deltar,1s,2s,6s,8s,8ar)-1,2,6,7,8,8a-hexahydro-beta,delta,6,8-tetrahydroxy-2-methyl-1-naphthaleneheptanoate, 8-((2s)-2-methylbutyrate)
57. Pravastatin Sodium [mi]
58. Dtxsid6047525
59. Pravastatin Sodium [jan]
60. Hy-b0165a
61. Pravastatin Sodium (jp17/usp)
62. Pravastatin Sodium [usan]
63. Hms2051p05
64. Hms3268l20
65. Hms3413e20
66. Pravastatin Sodium [vandf]
67. Hexahydronaphthalen-1-yl)heptanoate
68. Pravastatin Sodium [mart.]
69. Amy40517
70. Pravastatin Sodium [usp-rs]
71. Pravastatin Sodium [who-dd]
72. Tox21_111474
73. Tox21_300270
74. S3036
75. Akos015896504
76. Akos015964902
77. Ccg-100926
78. Cs-2003
79. Nc00176
80. Nsc 759253
81. Pravastatin Sodium [orange Book]
82. Ncgc00092370-01
83. Ncgc00254232-01
84. Pravastatin Sodium [ep Monograph]
85. 1-naphthaleneheptanoic Acid, 1,2,6,7,8,8a-hexahydro-2-methyl-8-(2-methyl-1-oxobutoxy)-beta,delta,6-trihydroxy-, Monosodium Salt, (1s-(1-alpha(beta-s*,delta-s*),2-alpha,6-alpha,8-beta(r*),8a-alpha))-
86. 1-naphthaleneheptanoic Acid, 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, Monosodium Salt, (1s-(1alpha(betas*,deltas*),2alpha,6alpha,8beta(r*),8aalpha))-
87. Bp164292
88. Pravastatin Sodium [usp Monograph]
89. P1796
90. D00893
91. Pravigard Pac Component Pravastatin Sodium
92. Pravastatin Sodium Component Of Pravigard Pac
93. Q27108059
94. Pravastatin Sodium Salt Hydrate, >=98% (hplc), Powder
95. 2-methyl-8-((s)-2-methylbutanoyloxy)-1,2,6,7,8,8a-
96. Sodium (3r,5r)-3,5-dihydroxy-7-((1s,2s,6s,8s,8ar)-6-hydroxy-
97. (?r,?r,1s,2s,6s,8s,8ar)-1,2,6,7,8,8a-hexahydro-?,?,6-trihydroxy-2-methyl-8-[(2s)-2-methyl-1-oxobutoxy]-1-naphthaleneheptanoic Acid Monosodium Salt
98. (3r,5r)-3,5-dihydroxy-7-((1s,2s,6s,8s,8ar)-6-hydroxy-2-methyl-8-(((s)-2-methylbutanoyl)oxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoicacid,sodiumsalt
99. 1-naphthaleneheptanoic Acid, 1,2,6,7,8,8a-hexahydro-.beta.,d,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, Monosodium Salt, (1s-(1.alpha.(.beta.s*,ds*),2.alpha.,6.alpha.,8.beta.(r*),8a.alpha.))-
100. Sodium (+)-(.beta.r,dr,1s,2s,6s,8s,8ar)-1,2,6,7,8,8a-hexahydro-.beta.,d,6,8-tetrahydroxy-2-methyl-1-naphthaleneheptanoate, 8-((2s)-2-methylbutyrate)
101. Sodium (3r,5r)-3,5-dihydroxy-7-((1s,2s,6s,8s,8ar)-6-hydroxy-2-methyl-8-((s)-2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoate
102. Sodium (3r,5r)-3,5-dihydroxy-7-[(1s,2s,6s,8s,8ar)-6-hydroxy-2-methyl-8-{[(2s)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoate
Molecular Weight | 446.5 g/mol |
---|---|
Molecular Formula | C23H35NaO7 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 11 |
Exact Mass | 446.22804773 g/mol |
Monoisotopic Mass | 446.22804773 g/mol |
Topological Polar Surface Area | 127 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 662 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Pravachol |
PubMed Health | Pravastatin (By mouth) |
Drug Classes | Antihyperlipidemic |
Drug Label | PRAVACHOL (pravastatin sodium) is one of a class of lipid-lowering compounds, the statins, which reduce cholesterol biosynthesis. These agents are competitive inhibitors of HMG-CoA reductase, the enzyme catalyzing the early rate-limiting step in ch... |
Active Ingredient | Pravastatin sodium |
Dosage Form | Tablet |
Route | Oral |
Strength | 10mg; 80mg; 40mg; 20mg |
Market Status | Prescription |
Company | Bristol Myers Squibb |
2 of 4 | |
---|---|
Drug Name | Pravastatin sodium |
Drug Label | Pravastatin sodium tablets are one of a class of lipid-lowering compounds, the HMG-CoA reductase inhibitors, which reduce cholesterol biosynthesis. These agents are competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase,... |
Active Ingredient | Pravastatin sodium |
Dosage Form | Tablet |
Route | oral; Oral |
Strength | 10mg; 80mg; 40mg; 20mg |
Market Status | Tentative Approval; Prescription |
Company | Mylan Pharms; Teva; Lupin Pharms; Apotex; Sandoz; Cipla; Watson Labs; Glenmark Generics; Teva Pharms; Pliva Hrvatska Doo; Zydus Pharms Usa; Dr Reddys Labs; Mylan |
3 of 4 | |
---|---|
Drug Name | Pravachol |
PubMed Health | Pravastatin (By mouth) |
Drug Classes | Antihyperlipidemic |
Drug Label | PRAVACHOL (pravastatin sodium) is one of a class of lipid-lowering compounds, the statins, which reduce cholesterol biosynthesis. These agents are competitive inhibitors of HMG-CoA reductase, the enzyme catalyzing the early rate-limiting step in ch... |
Active Ingredient | Pravastatin sodium |
Dosage Form | Tablet |
Route | Oral |
Strength | 10mg; 80mg; 40mg; 20mg |
Market Status | Prescription |
Company | Bristol Myers Squibb |
4 of 4 | |
---|---|
Drug Name | Pravastatin sodium |
Drug Label | Pravastatin sodium tablets are one of a class of lipid-lowering compounds, the HMG-CoA reductase inhibitors, which reduce cholesterol biosynthesis. These agents are competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase,... |
Active Ingredient | Pravastatin sodium |
Dosage Form | Tablet |
Route | oral; Oral |
Strength | 10mg; 80mg; 40mg; 20mg |
Market Status | Tentative Approval; Prescription |
Company | Mylan Pharms; Teva; Lupin Pharms; Apotex; Sandoz; Cipla; Watson Labs; Glenmark Generics; Teva Pharms; Pliva Hrvatska Doo; Zydus Pharms Usa; Dr Reddys Labs; Mylan |
Anticholesteremic Agents
Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis. (See all compounds classified as Hydroxymethylglutaryl-CoA Reductase Inhibitors.)
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14235
Submission : 1999-06-24
Status : Active
Type : II
Certificate Number : R1-CEP 2004-168 - Rev 01
Issue Date : 2021-03-04
Type : Chemical and TSE
Substance Number : 2059
Status : Valid
Registration Number : 218MF10474
Registrant's Address : No. 1, Tung-Hsing St. , Shu-Lin, New Taipei City 23850, Taiwan
Initial Date of Registration : 2006-04-27
Latest Date of Registration : --
GDUFA
DMF Review : Reviewed
Rev. Date : 2012-12-24
Pay. Date : 2012-11-13
DMF Number : 14729
Submission : 2000-02-25
Status : Active
Type : II
Registration Number : 218MF10727
Registrant's Address : 13 Pallagi u(´)t, Debrecen, 4042-Hungary
Initial Date of Registration : 2006-09-06
Latest Date of Registration : --
Available Reg Filing : ASMF |
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-07-07
Pay. Date : 2014-05-06
DMF Number : 27615
Submission : 2013-10-21
Status : Active
Type : II
NDC Package Code : 58623-0123
Start Marketing Date : 2018-05-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Kukjeon Pharmaceutical Co., Ltd.
Registration Date : 2022-06-07
Registration Number : 20220607-70-B-464-09
Manufacturer Name : Zhejiang Hisun Pharmaceutical Co., Ltd.
Manufacturer Address : No.56, Binhai Road, Jiaojiang District, Taizhou City, Zhejiang Province, China
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16309
Submission : 2002-12-13
Status : Inactive
Type : II
Certificate Number : R1-CEP 2002-009 - Rev 02
Issue Date : 2021-03-17
Type : Chemical
Substance Number : 2059
Status : Valid
NDC Package Code : 58623-0123
Start Marketing Date : 2018-05-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Kukjeon Pharmaceutical Co., Ltd.
Registration Date : 2022-06-07
Registration Number : 20220607-70-B-464-09
Manufacturer Name : Zhejiang Hisun Pharmaceutical Co., Ltd.
Manufacturer Address : No.56, Binhai Road, Jiaojiang District, Taizhou City, Zhejiang Province, China
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18709
Submission : 2005-08-24
Status : Inactive
Type : II
NDC Package Code : 58623-0123
Start Marketing Date : 2018-05-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Kukjeon Pharmaceutical Co., Ltd.
Registration Date : 2022-06-07
Registration Number : 20220607-70-B-464-09
Manufacturer Name : Zhejiang Hisun Pharmaceutical Co., Ltd.
Manufacturer Address : No.56, Binhai Road, Jiaojiang District, Taizhou City, Zhejiang Province, China
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16031
Submission : 2002-06-26
Status : Inactive
Type : II
Certificate Number : R1-CEP 2003-230 - Rev 00
Issue Date : 2009-12-14
Type : Chemical
Substance Number : 2059
Status : Withdrawn by Holder
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16975
Submission : 2003-11-20
Status : Inactive
Type : II
Certificate Number : R0-CEP 2005-016 - Rev 02
Issue Date : 2009-11-19
Type : Chemical
Substance Number : 2059
Status : Expired
Registration Number : 219MF10201
Registrant's Address : 1-6-1 Otemachi, Chiyoda-ku, Tokyo
Initial Date of Registration : 2007-06-13
Latest Date of Registration : --
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5968
Submission : 1985-08-29
Status : Inactive
Type : II
Certificate Number : R1-CEP 2003-122 - Rev 05
Issue Date : 2016-06-14
Type : Chemical
Substance Number : 2059
Status : Valid
Registrant Name : HKINNOEN Co., Ltd.
Registration Date : 2005-08-31
Registration Number : 20050831-70-B-192-07
Manufacturer Name : Daiichi Sankyo Chemical Pharma Co., Ltd.
Manufacturer Address : 389-4 Izumimachi Shimokawa, Aza-ohtsurugi, Iwaki, Fukushima 971-8183, Japan
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18580
Submission : 2005-08-11
Status : Inactive
Type : II
Certificate Number : R1-CEP 2006-167 - Rev 00
Issue Date : 2013-08-21
Type : Chemical
Substance Number : 2059
Status : Withdrawn by Holder
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15922
Submission : 2002-04-03
Status : Inactive
Type : II
Certificate Number : R1-CEP 2003-025 - Rev 00
Issue Date : 2009-04-14
Type : Chemical
Substance Number : 2059
Status : Withdrawn by Holder
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14235
Submission : 1999-06-24
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2012-12-24
Pay. Date : 2012-11-13
DMF Number : 14729
Submission : 2000-02-25
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17023
Submission : 2003-12-11
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16048
Submission : 2002-07-12
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5968
Submission : 1985-08-29
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7568
Submission : 1988-07-11
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16975
Submission : 2003-11-20
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16204
Submission : 2002-10-22
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15922
Submission : 2002-04-03
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16031
Submission : 2002-06-26
Status : Inactive
Type : II
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
Certificate Number : R1-CEP 2004-168 - Rev 01
Status : Valid
Issue Date : 2021-03-04
Type : Chemical and TSE
Substance Number : 2059
Certificate Number : R1-CEP 2003-101 - Rev 04
Status : Valid
Issue Date : 2019-11-05
Type : Chemical
Substance Number : 2059
Certificate Number : R1-CEP 2002-177 - Rev 02
Status : Valid
Issue Date : 2013-06-13
Type : Chemical
Substance Number : 2059
Certificate Number : R1-CEP 2010-018 - Rev 01
Status : Valid
Issue Date : 2017-10-31
Type : Chemical
Substance Number : 2059
Certificate Number : R1-CEP 2003-122 - Rev 05
Status : Valid
Issue Date : 2016-06-14
Type : Chemical
Substance Number : 2059
Certificate Number : R0-CEP 2005-016 - Rev 02
Status : Expired
Issue Date : 2009-11-19
Type : Chemical
Substance Number : 2059
Certificate Number : R1-CEP 2003-025 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2009-04-14
Type : Chemical
Substance Number : 2059
Certificate Number : R1-CEP 2006-167 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2013-08-21
Type : Chemical
Substance Number : 2059
Certificate Number : R1-CEP 2003-230 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2009-12-14
Type : Chemical
Substance Number : 2059
Certificate Number : R1-CEP 2003-073 - Rev 03
Status : Valid
Issue Date : 2022-02-25
Type : Chemical
Substance Number : 2059
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Pravastatin Zentiva
Dosage Form : Tabl
Dosage Strength : 20mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Pravastatin Zentiva
Dosage Form : Tabl
Dosage Strength : 20mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Pravastatin Zentiva
Dosage Form : Tabl
Dosage Strength : 40mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Pravastatin Zentiva
Dosage Form : Tabl
Dosage Strength : 40mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Aspen Pravastatin
Dosage Form : TAB
Dosage Strength : 10mg
Packaging : 30X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Aspen Pravastatin
Dosage Form : TAB
Dosage Strength : 20mg
Packaging : 30X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Aspen Pravastatin
Dosage Form : TAB
Dosage Strength : 40mg
Packaging : 30X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : PRAVASTATIN SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2006-10-23
Application Number : 76714
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : PRAVASTATIN SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : 20MG
Packaging :
Approval Date : 2006-10-23
Application Number : 76714
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : PRAVASTATIN SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date : 2006-10-23
Application Number : 76714
Regulatory Info : RX
Registration Country : USA
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
CAS Number :
Quantity Per Vial :
Sale Unit :
Price :
Details : In stock
Monograph :
Storage :
Code/Batch No : P0070.13
Pravastatin 1,1,3,3- Tetramethylbutylamin e (...
CAS Number : 151006-14-3
Quantity Per Vial : 200
Sale Unit : mg
Price : $285.00
Details : Material Origin- Animal-Cow; USMCA- No; KORUS...
Monograph :
Storage :
Code/Batch No : Catalog #1554192 / R131E0
CAS Number : 81131-70-6
Quantity Per Vial : 50
Sale Unit : mg
Price : $265.00
Details : Material Origin- Fermentation; USMCA- No; KOR...
Monograph :
Storage :
Code/Batch No : Catalog #1554206 / R08600
Pravastatin Related Compound A (10 mg) (Sodiu...
CAS Number : 81093-43-8
Quantity Per Vial : 10
Sale Unit : mg
Price : $835.00
Details : Material Origin- Animal (Cow)- Chemical Synth...
Monograph :
Storage :
Code/Batch No : Catalog #1554217 / R08280
Pravastatin Related Compound B (20 mg) (sodiu...
CAS Number : 81176-41-2
Quantity Per Vial : 20
Sale Unit : mg
Price : $814.00
Details : Material Origin- Chemical Synthesis; USMCA- N...
Monograph :
Storage :
Code/Batch No : Catalog #1554228 / F1G230
ABOUT THIS PAGE
A Pravastatin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pravastatin, including repackagers and relabelers. The FDA regulates Pravastatin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pravastatin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pravastatin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pravastatin supplier is an individual or a company that provides Pravastatin active pharmaceutical ingredient (API) or Pravastatin finished formulations upon request. The Pravastatin suppliers may include Pravastatin API manufacturers, exporters, distributors and traders.
click here to find a list of Pravastatin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Pravastatin DMF (Drug Master File) is a document detailing the whole manufacturing process of Pravastatin active pharmaceutical ingredient (API) in detail. Different forms of Pravastatin DMFs exist exist since differing nations have different regulations, such as Pravastatin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Pravastatin DMF submitted to regulatory agencies in the US is known as a USDMF. Pravastatin USDMF includes data on Pravastatin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Pravastatin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Pravastatin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Pravastatin Drug Master File in Japan (Pravastatin JDMF) empowers Pravastatin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Pravastatin JDMF during the approval evaluation for pharmaceutical products. At the time of Pravastatin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Pravastatin suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Pravastatin Drug Master File in Korea (Pravastatin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Pravastatin. The MFDS reviews the Pravastatin KDMF as part of the drug registration process and uses the information provided in the Pravastatin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Pravastatin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Pravastatin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Pravastatin suppliers with KDMF on PharmaCompass.
A Pravastatin CEP of the European Pharmacopoeia monograph is often referred to as a Pravastatin Certificate of Suitability (COS). The purpose of a Pravastatin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Pravastatin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Pravastatin to their clients by showing that a Pravastatin CEP has been issued for it. The manufacturer submits a Pravastatin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Pravastatin CEP holder for the record. Additionally, the data presented in the Pravastatin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Pravastatin DMF.
A Pravastatin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Pravastatin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Pravastatin suppliers with CEP (COS) on PharmaCompass.
A Pravastatin written confirmation (Pravastatin WC) is an official document issued by a regulatory agency to a Pravastatin manufacturer, verifying that the manufacturing facility of a Pravastatin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Pravastatin APIs or Pravastatin finished pharmaceutical products to another nation, regulatory agencies frequently require a Pravastatin WC (written confirmation) as part of the regulatory process.
click here to find a list of Pravastatin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Pravastatin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Pravastatin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Pravastatin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Pravastatin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Pravastatin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Pravastatin suppliers with NDC on PharmaCompass.
Pravastatin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pravastatin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pravastatin GMP manufacturer or Pravastatin GMP API supplier for your needs.
A Pravastatin CoA (Certificate of Analysis) is a formal document that attests to Pravastatin's compliance with Pravastatin specifications and serves as a tool for batch-level quality control.
Pravastatin CoA mostly includes findings from lab analyses of a specific batch. For each Pravastatin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pravastatin may be tested according to a variety of international standards, such as European Pharmacopoeia (Pravastatin EP), Pravastatin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pravastatin USP).
LOOKING FOR A SUPPLIER?